Skip to main content
NanoRepro AG logo

NanoRepro AG — Investor Relations & Filings

Ticker · NN6 ISIN · DE0006577109 LEI · 3912008FCA63AGIMEV74 F Manufacturing
Open in API
Filings indexed 412 across all filing types
Latest filing 2024-06-06 Earnings Release
Country DE Germany
Listing F NN6

About NanoRepro AG

https://www.nanorepro.com/en/

NanoRepro AG is a company specializing in the development, manufacturing, and distribution of CE-marked rapid diagnostic tests (self-tests) and food supplements. The products are designed for both home and professional use. The company's portfolio covers various health areas, including family planning, preventive healthcare, disease detection, food intolerances, allergies, and infectious diseases. The primary goal is to provide accuracy in self-diagnostics for rapid disease detection and health monitoring.

Recent filings

Filing Released Lang Actions
NanoRepro AG: Jahresabschluss 2023 bestatigt erwarteten Ruckgang bei Umsatz und Ergebnis nach Wegfall des COVID-19-Geschafts Starkes Wachstum mit Selbstdiagnostik und Nahrungserganzungsmitteln
Earnings Release Classification · 100% confidence The document is a press release from NanoRepro AG, dated June 6, 2024, titled "NanoRepro AG: Jahresabschluss 2023 bestätigt erwarteten Rückgang bei Umsatz und Ergebnis..." (Annual Financial Statements 2023 confirmed expected decline in revenue and earnings...). It explicitly mentions publishing the "testierten Zahlen für das abgelaufene Geschäftsjahr 2023" (audited figures for the past fiscal year 2023) and provides detailed financial results (Revenue, EBITDA, Net Income) for 2023 and outlook for 2024. The presence of the term "Jahresabschluss" (Annual Financial Statements) and the comprehensive nature of the financial review strongly suggest this is related to the Annual Report (10-K). However, the document is a news release announcing the results and points to the full report via a link ("Der vollständige Geschäftsbericht 2023 findet sich unter:"). According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement pointing to the full report is classified as a Report Publication Announcement (RPA). Since this is the official announcement of the audited annual figures, it fits best as an RPA, signaling the availability of the full annual report, rather than being the 10-K itself, although it contains substantial financial data typical of an ER or IR. Given the context of announcing the final, audited annual figures, RPA is the most precise classification for this specific news item. FY 2023
2024-06-06 German
NanoRepro AG: Aufsichtsrat bestatigt CEO Lisa Jungst
Board/Management Information Classification · 100% confidence The document is a news release dated April 30, 2024, announcing that the Supervisory Board of NanoRepro AG has unanimously extended the mandate of CEO Lisa Jüngst for three years. The key subject is the confirmation/extension of a senior executive's role. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. The document is short and appears to be an initial announcement rather than a comprehensive report, ruling out classifications like 10-K or IR. It is not a proxy statement (DEF 14A) or a director's dealing report (DIRS).
2024-04-30 German
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from NanoRepro AG titled "Veröffentlichung von Kapitalmarktinformationen" (Publication of Capital Market Information). The key content revolves around the "Abschlussmeldung" (Final Report) of an "Aktienrückkaufprogramm" (Share Buyback Program), detailing the number of shares acquired and the average price, referencing EU regulations (Regulation (EU) No 596/2014). This specific activity—reporting on the completion of a share repurchase—falls directly under the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing, POS is the most specific category available for share repurchase activity reports.
2024-04-29 German
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is titled "NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen" and explicitly details the "Erwerb eigener Aktien: 50. Zwischenmeldung" (Acquisition of own shares: 50th interim report). It provides a table showing the number of shares repurchased daily and the volume-weighted average price, referencing EU regulations concerning share buybacks (Article 5 of Regulation (EU) No 596/2014). This content directly relates to the company buying back or selling its own shares. Therefore, the appropriate classification is Transaction in Own Shares (POS). The document length is short (3422 chars) and it functions as a regulatory disclosure of the transaction details, not an announcement of a report, making POS more specific than RPA or RNS.
2024-04-29 German
NanoRepro AG: Auf Wachstumskurs NanoRepro berichtet uber vorlaufige Zahlen fur das Geschaftsjahr 2023 und aktuelle Entwicklungen
Earnings Release Classification · 100% confidence The document is a news release dated April 25, 2024, titled "NanoRepro AG: Auf Wachstumskurs – NanoRepro berichtet über vorläufige Zahlen für das Geschäftsjahr 2023 und aktuelle Entwicklungen" (NanoRepro AG: On growth trajectory – NanoRepro reports preliminary figures for the 2023 fiscal year and current developments). It explicitly states preliminary revenue figures for FY 2023 (EUR 3.2 million) and Q1 2024 (nearly EUR 1.1 million), discusses business segments, capital structure (equity ratio 97%), and provides an outlook. This content structure—announcing key financial metrics for a period before the full official report—is characteristic of an Earnings Release (ER). It is not a full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial announcement of results. FY 2023
2024-04-25 German
NanoRepro AG: Veroffentlichung von Kapitalmarktinformationen
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from NanoRepro AG, dated April 22, 2024, titled "NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen" (Publication of Capital Market Information). The key content revolves around the "Erwerb eigener Aktien: 49. Zwischenmeldung" (Acquisition of own shares: 49th Interim Report) detailing the number of shares repurchased between April 15 and April 19, 2024, in compliance with EU Market Abuse Regulation (MAR) articles. This specific activity—reporting on the company buying back its own stock—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a short announcement (under 5,000 characters) reporting on a transaction, the core subject matter is the share repurchase itself, making POS a more specific fit than the general RPA or RNS fallback. The document is not merely announcing a report but is the report/disclosure itself regarding the transaction.
2024-04-22 German

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.